Immunostimulatory oligonucleotide multimers

Details for Australian Patent Application No. 2005257938 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Kandimalla, Ekambar; Agrawal, Sudhir; Yu, Dong

Agent Freehills

Pub. Number AU-B-2005257938

PCT Pub. Number WO2006/002038

Priority 60/579,985 15.06.04 US; 60/599,362 06.08.04 US

Filing date 15 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 11 November 2010

International Classifications

A61K 31/7115 (2006.01) - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002038 Priority application(s): WO2006/002038

8 February 2007 Change of Name(s) of Applicant(s), Section 104

  Hybridon, Inc. The name of the applicant has been changed to Idera Pharmaceuticals, Inc.

11 November 2010 Application Accepted

  Published as AU-B-2005257938

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257949-Methods for predicting methotrexate polyglutamate levels using pharmacogenetics

2005257930-Apparatus and methods for converting a cryogenic fluid into gas